Skip to main content
GutCited

描述

Evidence from clinical trials of curcumin in ulcerative colitis patients is summarized, indicating potential benefits in reducing disease activity and maintaining remission.

Figure 4

Chart

Source Paper

Curcumin in Autoimmune and Rheumatic Diseases.

Nutrients (2019)

PMID: 31052496

DOI: 10.3390/nu11051004

Cite This Figure

![Figure 4: Evidence from clinical trials of curcumin in ulcerative colitis patients is summarized, indicating potential benefits in reducing disease activity and maintaining remission.]()

> Source: Melissa Yang et al. "Curcumin in Autoimmune and Rheumatic Diseases.." *Nutrients*, 2019. PMID: [31052496](https://pubmed.ncbi.nlm.nih.gov/31052496/)
<figure>
  <img src="" alt="Evidence from clinical trials of curcumin in ulcerative colitis patients is summarized, indicating potential benefits in reducing disease activity and maintaining remission." />
  <figcaption>Figure 4. Evidence from clinical trials of curcumin in ulcerative colitis patients is summarized, indicating potential benefits in reducing disease activity and maintaining remission.<br>  Source: Melissa Yang et al. "Curcumin in Autoimmune and Rheumatic Diseases.." <em>Nutrients</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31052496/">31052496</a></figcaption>
</figure>